How many investments has OCV Partners made?

OCV Partners has 26 tracked investments, 3 of which have exited, including 2 dated in the last 24 months.

What stage does OCV Partners invest at?

OCV Partners invests at the Seed, Series A, Series B, Series C stages.

Where is OCV Partners located?

OCV Partners is headquartered in Los Angeles, US.

Does OCV Partners lead rounds?

Yes, OCV Partners leads investment rounds.

Who does OCV Partners co-invest with?

OCV Partners most often shares deals with Crosscourt Ventures, FELIX CAPITAL, RA Capital, among 73 tracked co-investors.

OCV Partners

Venture capital

Los Angeles · Seed–Series C · 6 people tracked

Also known as OCV · OCV MANAGEMENT, LLC

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into OCV Partners

Paths you didn't know you had: your email and LinkedIn already hold routes to the OCV Partners team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

OCV Partners invests in teams building disruptive technology and healthcare platforms, drawing on its partners' experience as former founders who have built and scaled companies to IPO and beyond. On the technology side it focuses on subscription software, recurring-revenue business models, SaaS, fintech, and proptech, citing expertise from growing and acquiring over 165 software companies. In healthcare it backs founders in healthcare SaaS, digital health, medtech, and biotech, favoring companies that enable precision or targeted care, improve treatment decisions and workflows, expand equitable access, and speed the discovery of new treatments. The firm describes itself as flexible capital that prefers to lead rounds but does not require it, aiming to create asymmetric advantages for founders.

Invests inAI & Machine Learning Biotech Digital Health Enterprise Software Fintech Healthtech Medical Devices PropTech SaaS Los Angeles United States

Source: firm website, verified Sep 29, 2026.

Leave your own feedback

Stage

Seed–Series C

Los Angeles, CA, US

Leads rounds

Leads

Instruments

Equity

Founded

2022

Last 12 months

1 investment

Private fund assets

$172.9M

VC funds

Tracked investments

IPOs

Acquisitions

Team · 6 people

from the firm's website & public directories

Richard Ressler· Co-Founder, Chairman· Los Angeles, CA

Richard Ressler co-founded OCV in 2016 and chairs its executive committee through an agreement with Orchard Capital. He also co-founded CIM in 1994 and the predecessor of OFSAM in 2001, chairing committees at both, with a career focused on real asset, infrastructure, and credit investing. Earlier he served as Vice Chairman of Brooke Group Limited (predecessor of Vector Group), worked at Drexel Burnham Lambert on M&A and middle-market financing, and began his career at Cravath, Swaine and Moore. He holds a B.A. from Brown University and J.D. and M.B.A. degrees from Columbia University.

Mark Yung· General Partner

Andy Liu· Partner· Los Angeles, CAin

Andy Liu focuses on software investments at OCV Partners and works on adding operating value across the portfolio. He previously worked in Morgan Stanley's technology investment banking group covering SaaS and FinTech clients, led go-to-market teams at Addepar, and earlier worked in consulting at Deloitte on financial services and technology. He holds an M.B.A. from UC Berkeley Haas and a B.A. in Business Economics from UCLA.

Chris Bostick· Partner· Los Angeles, CAin

Chris Bostick focuses on healthcare investments at OCV Partners, working on technologies that apply interdisciplinary methods to precision medicine. Before joining OCV, he completed postdoctoral work at the Institute for Genomic Medicine at Columbia University, studying precision medicine approaches to genetic neurological disorders, and earlier researched drug metabolism, bioelectronics/biosensors, and nanotechnology during his PhD. He holds a B.S. in Biology with a business minor from Cornell University and a Ph.D. in Pharmacological and Pharmaceutical Sciences from West Virginia University.

Hemi Zucker· Managing Partner· Los Angeles, CAin

Hemi Zucker co-founded j2 Global in 1996 and served in multiple executive roles including CEO, President, COO, CMO, and CFO during the company's 1999 IPO, leading it through more than 160 acquisitions and expansion into cloud services, patent licensing, and digital media. Before j2, he worked at Motorola in the U.S. and Israel, where he helped launch Israel's first cellular company and worked on early wireless data networks. He holds a B.A. in Economics from Tel Aviv University.

Joe Sassi· Senior Associate· Los Angeles, Californiain

What they invest in

from 22 of 26 portfolio companies

Healthtech ×10AI & Machine Learning ×8Biotech ×6Enterprise Software ×4Consumer ×3Creator Economy ×3Deep Tech ×3Fintech ×3

HQs:United States×16Denmark×1Israel×1Mexico×1

Who they back

founder profiles across 13 portfolio companies

46%

solo founders

6 of 13 mapped founding teams

47%

repeat founders

of 15 founders with career history

Founding team size:solo founder×62 founders×33 founders×24+ founders×2

Where their founders studiedfrom 14 founders with education data

Technion ×2The Johns Hopkins University School of Medicine ×2UCLA ×2University of Pennsylvania ×2

What their founders studiedfrom 15 founders with field-of-study data

Life Sciences ×4Business & Management ×3Computer Science ×3Economics ×2Engineering ×2Humanities ×2Physics ×2

Where their founders worked beforefrom 15 founders with career history

Doblet ×2Google ×2

Investments · 26 tracked

founders shown can be your intro path

By year:2026 · 1 2025 · 1 2024 · 3 2022 · 2 2021 · 3 2019 · 1 2018 · 314 dated

Praxispraxismedicines.com in 𝕏NASDAQ: PRAX

Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy.

BiotechDeep TechHealthtechBoston, US

Steve Petrou(Co-Founder, President of Research & Development)in Kiran Reddy(Executive Officer, Director)inMarcio Souza(President & Chief Executive Officer)in

BoardNicholas G. Galakatos(Director)in

Co-investorsAvoro Capital Advisors Capria Ventures Alameda Research APOLLO PROJECTS Blackstone Clarus Ventures +6 more

Precision BioSciencesprecisionbiosciences.com in 𝕏NASDAQ: DTIL

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

MATTHEW KANE(Executive Officer, Director)Jeff Smith(Co-founder)in Derek Jantz(Co-founder)inTODD MELBY(Executive Officer)in Michael Amoroso(President, Chief Executive Officer)in

Board ROBERT ADELMAN(Director)

Co-investorsage1 Agent Capital Aliment Capital Brace Pharma F-Prime Capital OUP (Osage University Partners)+6 more

SafeBreach Attack Simulation Platformsafebreach.com in 𝕏✓ verified

SafeBreach offers a continuous threat exposure management (CTEM) platform that combines breach and attack simulation, attack path validation, and an AI agent to help enterprise security teams identify, prioritize, and remediate cyber risk.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaS

Guy Bejerano(Founder)inItzik Kotler(Founder)in Michal Weiner(Chief Financial Officer)in Raman Kumar(Chief Customer Officer)in

Co-investorsBain Capital DTCP 33N Bright Pixel Capital Dnx Ventures Emerald Development Managers +2 more

ByHeartbyheart.com inJul 2021

ByHeart is an infant formula company that manufactures science-driven baby formula with its own manufacturing process and supply chain.

ConsumerDirect to ConsumerFoodTechHealthtechNew York, US

Ron Belldegrun(Co-founder)inMia Funt(Founder)in Georg Krause-Vilmar(Executive Officer)in Niall Mullane(Executive Officer)in

Board Amy Schulman(Director)

Board seatHemi Zucker· per SEC Form D

Co-investorsEvolution VC Partners Gaingels AF Ventures Polaris Partners Red Sea Ventures Vida Ventures

Figure 8museumoficecream.com in

Museum of Ice Cream operates interactive, ice cream-themed attractions featuring immersive rooms, a sprinkle pool, novelty desserts, cocktails, and retail products.

ConsumerMedia & Entertainment

Manish V.(Founder)in

Co-investorsElizabeth Street Ventures Maywic Select Investments

Figure8figure-8.co in

Figure 8 is an experience-first company that designs and operates immersive venues known as "experiums," including the Museum of Ice Cream and Home Quart brands.

ConsumerCreator EconomyMedia & EntertainmentMexico City, MX

Maryellis Bunn(Founder & CEO)Manish Vora(Co-founder)

Co-investorsElizabeth Street Ventures

Finch Therapeuticsfinchtherapeutics.com in 𝕏Feb 2018

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

BiotechHealthtechMedical DevicesSomerville, US

Mark Smith(Executive Officer, Director)in Matt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)

Co-investorsAvenir Growth Capital B3 Holding Kleinmuntz Associates Octave Ventures Llc OMX Ventures Shumway Capital +2 more

Hemihemihealth.comSep 2018 · $10M

Hemi is a specialized private clinic for diagnosing and treating headache disorders — including migraine, tension headache, cluster headache, concussion, and whiplash-related symptoms — in both children and adults.

Digital HealthHealthtechWellness & FitnessFrederiksberg, DK

Co-investorsAlliance VC Alliance Venture Crowberry Capital Sondo Capital Accel Ribbit Capital

Invoice2go2go.comSep 2018 · $10M

Subscription-based mobile app helping small business owners win jobs, track payments, and manage client payment options.

Co-investorsAccel Ribbit Capital

Lexenselexense.com

Lexense partners with professional services practices, providing AI tools, capital, and operational support to build a modern professional services platform.

AI & Machine LearningEnterprise SoftwareLegalTechTel Aviv, IL

Ilya Schukin(Founder)in

Co-investorsfresh.fund

Ockam fintech-blockchainockam.io

Ockam is an open-source library that enables developers to build secure communication channels with end-to-end encryption and mutual authentication across any network, cloud, or on-premises infrastructure.

CybersecurityDeveloper ToolsSan Francisco, US

Matthew Gregory(Founder)in

Co-investorsAlumni Ventures Aspect Ventures Beaconsfield Capital Core Ventures Group Gaingels Mana Ventures +3 more

Olapicolapic.com in 𝕏Acquired

Social Native (at olapic.com) offers an AI-powered creator marketing platform trained on 1.8M+ creator collaborations and $8B in paid media, predicting brief, creator, and platform performance before spend.

AI & Machine LearningCreator EconomyE-commerceMarketing TechSocialNew York, US

David Shadpour(Founder & CEO)in Eytan Elbaz(Co-Founder)inJose De Cabo(Executive Officer, Director)Luis Sanz Arilla(Executive Officer, Director)

BoardBen Lin(Director)

Co-investorsAct One Ventures Contour Venture Partners FELIX CAPITAL FJ Labs LFX Venture Partners Scout Ventures +4 more

Orcaorca.fyi in 𝕏Apr 2021 · $13M

Orca offers a mobile banking platform targeting young adults, featuring peer-to-peer money transfers, group bill-splitting, local merchant discounts, and integrated spending and savings tools.

FintechSan Francisco, US

DY (Founder)in Tim Qin(Founder)inGrace Kwan(Founder)Yutaro Mori(Founder)

Co-investorsY Combinator 6th Man Ventures Collab+Currency First Circle MizMaa Ventures Musha Ventures +2 more

Orcaorca.so in 𝕏Apr 2021 · $13M

Orca is a liquidity protocol and trading platform on the Solana blockchain that enables users to discover, deploy, and manage yield strategies across decentralized liquidity pools.

Crypto & Web3Fintech

Michael Hwang(CEO)in

Co-investors6th Man Ventures Collab+Currency Foundation Capital Marin Digital Ventures Placeholder VC RockawayX +5 more

Orcaorcawater.life inMay 2024 · $23M

Orca Water builds a water monitoring and predictive leak detection system that uses ultrasonic sensors and machine learning to visualize and localize water use down to specific fixtures via an interactive dashboard.

AI & Machine LearningCleantechIoT

Co-investorsForesight Canada Innovation UBC Ankona Capital Brighton Park Capital Enza Capital MizMaa Ventures +2 more

Orcaorcainc.com in 𝕏May 2024 · $23M

Orca is a software platform that modernizes venture capital fund management by automating operations and streamlining workflows.

Enterprise SoftwareFintechSaaS

Shalom(CEO and Founder)Itzik(Head of Growth)Artem(Chief Product Officer)Meital(CFO)

Co-investorsF2 Venture Capital State of Mind Ventures Ankona Capital Brighton Park Capital Enza Capital MizMaa Ventures +2 more

Orca AIorca-ai.io inMay 2025 · $72.5M

Orca AI applies computer vision and deep learning to maritime shipping, providing situational awareness and automation tools to help commercial vessels navigate more safely and operate more efficiently.

AI & Machine LearningDeep TechLogistics & Supply ChainMobility & Transportation

Yarden Gross(Co-founder & CEO)in Dor Raviv(Co-founder & CTO)in Shoval Bolotin(VP Product / Operations)inFabrizio Ferraro(Global Sales Lead)inLirit(CFO)inAmit(VP R&D)in

Co-investorsAnkona Capital Brighton Park Capital Crosscourt Ventures Gaingels MizMaa Ventures theDOCK +2 more

Ossioossio.io in 𝕏Mar 2019 · $22M

OSSIO develops OSSIOfiber, a bio-integrative bone fixation implant material made from natural mineral fibers that provides stability during healing and integrates fully into bone over 18-24 months, avoiding permanent metal hardware.

BiotechHealthtechMedical DevicesNew MaterialsPalmetto, US

Orahn Preiss-Bloom(Founder & Chief Innovation Officer)in Brian Verrier(Chief Executive Officer)inBrennan Marilla(Chief Commercial and Operating Officer)in Moshe Shneor(Chief Financial Officer)inGregory C. Berlet(Chief Medical Officer)

Co-investorsMVM Life Science Partners Questa Capital Secocha Ventures

Ozetteozette.com in 𝕏Jul 2022

Ozette runs a vertically integrated, AI-enabled lab and platform that generates high-dimensional spectral cytometry data and analyzes it to produce reproducible biomarker endpoints for clinical trials.

AI & Machine LearningBiotechHealthtech

Greg Finak(Founder)inEvan Greene(Founder)inAli Ansary(Founder)inRaphael Gottardo(Founder)

Co-investorsAllen Institute for AI (AI2) Incubator Alpha Ascent Ventures Llc M12 (Microsoft's Venture Fund)Alexandria Cercano Management Madrona Venture Group

Rad AIradai.com in 𝕏

Rad AI develops generative AI models and automation solutions specifically designed for radiology and healthcare workflows.

AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSan Francisco, US

Dr. Jeff Chang(Co-founder)in Doktor Gurson(Founder)in Jeff Chang(Founder)in

Board Stuart Peterson(Director)in Bruce Armstrong(Director)in

Partner Chris Bostick· led

Co-investorsAlpha Partners Array Ventures Management Llc Artis Ventures City Light Corewell Health Ventures Crosscourt Ventures +13 more

Social Nativesocialnative.ai in 𝕏

Social Native runs an AI-powered creator marketing platform that matches brands with content creators, predicts campaign performance, and manages briefs-to-payout, drawing on data from 1.8M+ creator collaborations and $8B in paid media.

AI & Machine LearningCreator EconomyMarketing TechSaaSBeverly Hills, US

David Shadpour(Founder)inJose de Cabo(Founder)Luis Sanz(Founder)Pau Sabria(Founder)

BoardJordan Levy(Director)

Co-investorsBow Capital FELIX CAPITAL Miramar Venture Partners Scout Ventures TenOneTen Ventures Act One Ventures +1 more

TechStyle Fashion Grouptechstylefashiongroup.com in

Online subscription fashion retailer carrying shoes, handbags, jewelry, and denim through brands including Fabletics, Justfab, ShoeDazzle, and Savage x Fenty.

Laura Jones Joukovski in

Co-investorsCrosscut Ventures Manhattan West L Catterton Neuberger Berman Sugar Capital

Torl Biotorlbio.comApr 2024

TORL BioTherapeutics develops antibody-drug conjugates (ADCs) targeting Claudin 6 (CLDN6) for the treatment of solid tumors such as ovarian, lung, endometrial, and testicular cancers.

BiotechHealthtechCulver City, US

Dave LicatainAran Maree M.D.inMark Alles(Executive Officer, Director)Mark Attanasio(Director)David Licata(Executive Officer, Director)Neil O'Brien(Director)

Partner Chris Bostick· led

Co-investorsRA Capital Cowen Healthcare Investments Goldman Sachs Perceptive Xontogeny Venture Vertex Ventures HC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

MeridianMade, Inc.1200 Pharma Ozette Technologies, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 3

2 IPOs · 1 acquisitions · showing 2

PraxisNASDAQ: PRAXPrecision BioSciencesNASDAQ: DTIL

Portfolio news

latest coverage across their companies

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update - BioSpace

Precision BioSciences · biospace.com · Aug 6, 2026

OSSIO Raises the Bar for Sports Medicine at Specialty’s Major Meeting

Ossio · finance.yahoo.com · Jul 6, 2026

Female-led Danish startup Hemi Health raises €4 million to expand migraine and concussion care internationally | EU-Startups

Hemi · eu-startups.com · Feb 20, 2026

Rad AI Raises Additional $8M in Funding

Rad AI · finsmes.com · May 20, 2025

Orca AI raises $72.5M to advance autonomous shipping - Orca AI

Orca AI · orca-ai.io · May 6, 2025

Frequently asked questions

How many investments has OCV Partners made?: OCV Partners has 26 tracked investments, 3 of which have exited, including 2 dated in the last 24 months.
What stage does OCV Partners invest at?: OCV Partners invests at the Seed, Series A, Series B, Series C stages.
What sectors does OCV Partners focus on?: OCV Partners focuses on AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, PropTech, SaaS.
Where is OCV Partners located?: OCV Partners is headquartered in Los Angeles, US.
Does OCV Partners lead rounds?: Yes, OCV Partners leads investment rounds.
Who does OCV Partners co-invest with?: OCV Partners most often shares deals with Crosscourt Ventures, FELIX CAPITAL, RA Capital, among 73 tracked co-investors.

From the blog

visit blog ↗

Recent posts cover portfolio company developments in healthcare and maritime AI, including Rad AI's radiology generative AI products, its $60M Series C raise and RSNA Ventures partnership, and Orca AI's $72.5M raise for autonomous ship navigation. AI summary

RSNA Ventures and Rad AI Announce Strategic Partnership to Accelerate Innovation in RadiologyOct 2025The Radiological Society of North America launched RSNA Ventures and partnered with Rad AI to integrate its peer-reviewed content into radiologists' generative AI workflow at the point of care. Boosted by defense and Starlink, Orca AI pulls in $72.5M for its autonomous shipping platformMay 2025Orca AI raised a $72.5M Series B led by Brighton Park Capital for its AI autonomous ship navigation platform, driven by defense demand and Starlink connectivity. Rad AI Closes $60M Series C to Further Solidify Leadership in Healthcare Generative AIJan 2025Rad AI closed a $60M Series C led by Transformation Capital at a $525M valuation to expand its generative AI radiology reporting and follow-up solutions.

Media · Podcasts & interviews

featuring the team

Chris Bostick, OCV Partners

socaltech · Chris Bostick

Images

Similar investors

Khosla Ventures

Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.

$100K – $20M

Norwest Venture Partners

Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.

$10M – $30M

OMERS Ventures

OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.

$5M – $25M

OneVentures

OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.

$3.3M – $13.2M

Bayern Kapital

Bayern Kapital is a public venture capital and growth investor backing innovative Bavarian high-tech, deep tech and life sciences start-ups and scale-ups, acting as an anchor investor across multiple funding rounds.

$275K – $55M